In 2005, a randomized controlled pilot trial, researchers led by Anna-Leila Williams, et. al., examined the potential impact of Metta meditation and massage on the quality of life (QOL) among individuals with late-stage acquired immunodeficiency syndrome (AIDS). This study aimed to explore how these interventions may independently and interactively affect QOL in this population.

Fifty-eight residents, comprising 43% women and diagnosed with either AIDS or comorbidities, participated in the trial. They were randomly assigned to one of four groups: meditation, massage, combined meditation and massage, or standard care. The meditation group received instructional guidance and practiced with a daily meditation audiocassette, while a certified massage therapist administered massage sessions lasting 30 minutes per day, five days per week.

The primary outcome measure was the change in overall and transcendent (spiritual) scores on the Missoula-Vitas QOL Index after 8 weeks of intervention.

Results indicated that participants in the combined meditation and massage group experienced significant improvements in both overall (p = 0.005) and transcendent (p = 0.01) QOL scores compared to baseline. Importantly, these improvements were notably greater (p < 0.05) than those observed in the meditation, massage, and control groups.

The findings suggest that the synergistic effects of meditation and massage may have a significantly positive influence on overall and spiritual aspects of QOL in individuals with late-stage disease compared to standard care or either intervention alone.

This study underscores the potential benefits of integrating complementary approaches, such as meditation and massage, into the care of individuals facing end-of-life challenges, highlighting the importance of addressing both physical and spiritual needs in enhancing QOL outcomes.

Reference: Williams, A. L., Selwyn, P. A., Liberti, L., Molde, S., Njike, V. Y., McCorkle, R., & Katz, D. L. (2005). A randomized controlled trial of meditation and massage effects on quality of life in people with late-stage disease: a pilot study. Journal of palliative medicine, 8(5), 939-952.